Skip to main content
Clinical Trials/NCT01320514
NCT01320514UnknownNot Applicable

A Randomized, Controlled Study to Evaluate Safety and Efficacy of Fibrin Sealant VH S/D 4 S-APR (Artiss) for Tissue Adherence and Hemostasis and To Improve Wound Healing in Subjects Undergoing Endoscopic Browlift

Nguyen, Davis B., M.D.1 site in 1 country10 target enrollmentStarted: December 2010Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
10
Locations
1
Primary Endpoint
Comparison of ecchymosis and edema

Study Overview

Brief Summary

The primary objective is to evaluate the safety and efficacy of Artiss (Fibrin Sealant) in reducing the incidence of early postoperative bruising and swelling.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subjects planned for endoscopic browlift, subjects who read, understand and sign the written informed consent, healthy female or male subjects, 18-75 years old, and subjects who are able and willing to comply with the protocal requirements

Exclusion Criteria

  • Subjects who had previous browlift, subjects indicated for concurrent facial surgeries, subjects considered to be active smokers, subjects with ecchymosis/edema on day 0, significant laboratory abnormalities, subjects with known bleeding or coagulation disorders, subjects treated with anti-coagulants.

Arms & Interventions

Fibrin Sealant (Artiss)

Intervention: Fibrin Sealant (Artiss) (Drug)

Outcomes

Primary Outcomes

Comparison of ecchymosis and edema

Time Frame: 30 days

Secondary Outcomes

  • Resolution of ecchymosis and edema, incidence of hematoma/seroma(30 days)

Investigators

Sponsor
Nguyen, Davis B., M.D.
Sponsor Class
Indiv

Study Sites (1)

Loading locations...

Similar Trials